Champions Oncology Inc (NASDAQ: CSBR) stock closed at $5.84 on 12/11/24 after a major increase of 12.1%. Moreover, exceptionally high trading volume at 1772% of normal accompanied the advance. The stock has been weak relative to the market over the last nine months but has risen 35.2% during the last week.
Current PriceTarget Research Rating
Champions Oncology is currently unrated.
Rating Review
The stock is currently unrated.